Loading…
Arvinas, Inc. is projected to rise to $9.69 by 2027, a +17% move from its current price of $8.27. ARVN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $8.09 | $8.27 | $8.45 | 0.00% |
| Jul 13 | $8.02 | $8.27 | $8.53 | 0.00% |
| Jul 14 | $7.97 | $8.27 | $8.58 | 0.00% |
| Jul 15 | $7.92 | $8.27 | $8.63 | 0.00% |
| Jul 16 | $7.88 | $8.27 | $8.68 | +0.01% |
| Jul 17 | $7.85 | $8.27 | $8.72 | +0.01% |
| Jul 18 | $7.81 | $8.27 | $8.76 | +0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.81 | $8.27 | $8.76 | +0.01% |
| Week 2 | $7.63 | $8.27 | $8.97 | +0.02% |
| Week 3 | $7.49 | $8.27 | $9.13 | +0.02% |
| Week 4 | $7.38 | $8.27 | $9.27 | +0.03% |
| Week 5 | $7.28 | $8.27 | $9.40 | +0.04% |
| Week 6 | $7.20 | $8.27 | $9.51 | +0.05% |
| Week 7 | $7.12 | $8.27 | $9.62 | +0.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Arvinas, Inc. is a clinical-stage biotechnology company that develops therapies to degrade disease-causing proteins. It focuses on proteolysis targeting chimeras (PROTAC) targeted protein degraders designed to harness the body's natural protein disposal system.
Its programs include ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, as well as Bavdegalutamide (ARV-110) and Luxdegalutamide (ARV-766) as investigational PROTAC degraders. The company has collaborations with Pfizer, Genentech, Roche, Carrick Therapeutics, and Bayer. Arvinas was founded in 2013 and is based in New Haven, Connecticut.
Arvinas, Inc. (ARVN) operates in the Healthcare sector and trades with a current price of $8.29 and a market cap of $534.88M, ranking 2851. The stock’s price forecast indicates a path of gradual appreciation over the coming years.
The 2026 average is $8.29 with a neutral sentiment, and anticipated upside grows through 2027–2050, including a 2027 average of $10.03 and a 2027 max of $13.22 (bullish), rising to a 2040 average of $23.13 and a 2050 average of $34.19 with substantial upside (bullish). The forecast also shows year-by-year min/avg/max values and ROIs, highlighting a long-run bullish trend from 2027 onward.
A major floor 26.5% below — a decisive break under it would weaken the trend.
The nearest floor, 15.6% below — buyers have tended to step in here.
The nearest ceiling, 8.6% above — a clean break opens room to run.
A major ceiling 67.2% above — clearing it would confirm fresh momentum.
Key ARVN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARVN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $8.48 | Sell | $8.41 | Sell |
| MA 10 | $8.36 | Sell | $8.33 | Sell |
| MA 20 | $8.02 | Buy | $8.24 | Buy |
| MA 50 | $8.63 | Sell | $8.73 | Sell |
| MA 100 | $10.13 | Sell | $9.54 | Sell |
| MA 200 | $10.70 | Sell | $10.40 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.43 | Neutral |
| Stoch RSI (14) | 51.02 | Neutral |
| CCI (20) | 46.43 | Neutral |
| Williams %R (14) | -37.65 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | 1.60 | Buy |
| Bollinger %B (20,2) | 0.65 | Neutral |
| Stochastic %K (14) | 62.35 | Neutral |
| TRIX (15) | -0.18 | Sell |
| Awesome (5,34) | 0.39 | Buy |
| Ultimate (7,14,28) | 52.51 | Neutral |
| Momentum (10) | 0.24 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 8.55 | Sell |
| ADX (14) | 17.73 | Neutral |
| ATR (14) | 0.15 | Info |
The 30-day technical picture is NEUTRAL with RSI(14) at 50. The simple moving averages place the stock around key levels, with SMA50 at $8.97 and SMA200 at $10.67. Nearby support is noted at $6.98 and resistance at $9.10, framing a 30-day price range from $7.02 to $9.79.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.98 | $8.27 | $10.40 | 0% | Neutral | |
| $7.86 | $9.69 | $12.53 | +17% | Neutral | |
| $7.94 | $10.00 | $13.32 | +21% | Bullish | |
| $7.79 | $9.98 | $13.61 | +21% | Bullish | |
| $7.73 | $10.05 | $14.00 | +22% | Bullish | |
| $8.00 | $10.56 | $14.97 | +28% | Bullish | |
| $9.14 | $12.22 | $17.59 | +48% | Bullish | |
| $9.81 | $13.28 | $19.40 | +61% | Bullish | |
| $10.21 | $13.98 | $20.69 | +69% | Bullish | |
| $10.57 | $14.64 | $21.93 | +77% | Bullish | |
| $14.40 | $20.95 | $33.05 | +153% | Bullish | |
| $19.62 | $31.02 | $52.81 | +275% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $6.98 | $8.27 | $10.03 | +0.00% |
| August 2026 | $7.20 | $8.46 | $10.16 | +2.26% |
| September 2026 | $7.01 | $8.28 | $10.03 | -2.11% |
| October 2026 | $7.05 | $8.36 | $10.20 | +0.96% |
| November 2026 | $7.15 | $8.51 | $10.45 | +1.79% |
| December 2026 | $7.04 | $8.42 | $10.40 | -1.06% |
Click any year to see its month-by-month ARVN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ARVN to range from $6.98 to $10.40 through 2026. The $8.27 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ARVN price prediction for 2027 points to an average of $9.69 (low $7.86, high $12.53) — a potential gain of +17% on today's $8.27. A consolidation phase looks the most probable path here.
In 2028, ARVN is projected to trade between $7.94 and $13.32, averaging $10.00 — a potential gain of +21% from today's $8.27. That is up +3% on the projected 2027 average. Momentum favours further upside here.
Arvinas, Inc.'s 2029 outlook centres on $9.98, within a $7.79 to $13.61 range. That is 0% versus the projected 2028 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ARVN could reach as high as $14.00, with a base case around $10.05 and support toward $7.73 — roughly +22% from $8.27. Momentum favours further upside here.
Expect ARVN to range from $8.00 to $14.97 through 2031. The $10.56 average target implies a +28% move from current prices. That is up +5% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The ARVN price prediction for 2032 points to an average of $12.22 (low $9.14, high $17.59) — a potential gain of +48% on today's $8.27. Momentum favours further upside here.
In 2033, ARVN is projected to trade between $9.81 and $19.40, averaging $13.28 — a potential gain of +61% from today's $8.27. That is up +9% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Arvinas, Inc.'s 2034 outlook centres on $13.98, within a $10.21 to $20.69 range. That is up +5% on the projected 2033 average. That marks a +69% change versus current levels. Momentum favours further upside here.
By 2035, ARVN could reach as high as $21.93, with a base case around $14.64 and support toward $10.57 — roughly +77% from $8.27. Buyers look set to stay in control over this stretch.
Expect ARVN to range from $14.40 to $33.05 through 2040. The $20.95 average target implies a +153% move from current prices. That is up +43% on the projected 2035 average. Momentum favours further upside here.
The ARVN price prediction for 2050 points to an average of $31.02 (low $19.62, high $52.81) — a potential gain of +275% on today's $8.27. Buyers look set to stay in control over this stretch.
Investing $1,000 in ARVN today (≈ 120.918984 ARVN) could be worth
$3,750.39
+$2,750.39 (+275%) by 2050 · US Dollar
Based on the average projected ARVN price of $31.02 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARVNwould be worth at today's price.
$1,000 invested in ARVN on Jul 10, 2025 (≈ 126.742714 ARVN) would be worth
$1,048.16
+$48.16 (+4.8%) today · 1.05× · US Dollar
Based on a ARVN entry price of $7.89 vs. today's $8.27.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.39 | $985.7 | -1.4% |
| 1 month ago | $6.98 | $1,184.81 | +18.5% |
| 3 months ago | $10.82 | $764.33 | -23.6% |
| 6 months ago | $12.15 | $680.66 | -31.9% |
| 1 year ago | $7.89 | $1,048.16 | +4.8% |
| All time (5.0y) ago | $80.67 | $102.52 | -89.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARVN forecast.
Our base-case forecast reaches $17.00 around 2040.
Implied market cap at $17.00: $1.1B
The multi-year forecast paints a bullish path beyond 2026, with a steady rise in the average price and rising ROIs. In 2026 the min/avg/max are $6.98/$8.29/$10.56, with ROI 0 and sentiment NEUTRAL. By 2027 the average is $10.03 and the max is $13.22 (ROI 21, sentiment BULLISH).
The sequence continues through 2028 ($10.26 average, ROI 23.7), 2029 ($10.09 average, ROI 21.7), and 2030 ($10.49 average, ROI 26.6). By 2032 the average reaches $13.02 (ROI 57.1) and by 2033 $14.43 (ROI 74). The forecast progresses to 2034 $15.00 (ROI 80.9) and 2035 $15.68 (ROI 89.2).
Long-horizon values show substantial potential with 2040 averaging $23.13 (ROI 179) and 2050 averaging $34.19 (ROI 312.4), both labeled BULLISH. These figures illustrate a long-run growth trajectory, though they are estimates and not guarantees, and actual results may vary.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $10.49 with a min of $7.88 and a max of $15.04, and a projected ROI of 26.6% with a bullish sentiment.
The forecast indicates bullish sentiment from 2027 onward, with the average price rising to $10.03 in 2027 and continuing higher to $34.19 in 2050, and ROIs reaching 21% in 2027 and up to 312.4% by 2050.
Yes. The 2033 forecast shows a max of $21.82, and the 2034 forecast shows a max of $23.03, with the 2040 max at $38.16 and the 2050 max at $61.42.
The current price is $8.29 and the market cap is $534.88M.
RSI(14) is 50, indicating neutral momentum. SMA50 is $8.97 and SMA200 is $10.67, with support at $6.98 and resistance at $9.10. The 30-day range is $7.02 to $9.79.
Arvinas, Inc. Community Discussion
0Share your Arvinas, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.